Nawsherwan Mohammad: Exploring Thrombophilia in 2026
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn:
“Thrombophilia in 2026
The modern approach to thrombophilia emphasizes precision medicine, recommending selective testing only when the results are likely to influence clinical management.
Testing is appropriate for patients with unprovoked or recurrent VTE, thrombosis at unusual sites, recurrent pregnancy loss, a strong family history, or suspected antiphospholipid syndrome, while it is generally not recommended for provoked VTE, during acute thrombosis or anticoagulation, or as routine screening of relatives.
Current evaluation focuses on high-yield tests, including Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies, and antiphospholipid antibodies.
Treatment decisions should be based primarily on the patient’s clinical risk rather than thrombophilia status alone.
High-risk thrombophilias often require specialist care and extended anticoagulation, while emerging evidence supports the use of DOACs in selected patients.
Special populations, particularly pregnant women and patients with antithrombin deficiency, require individualized risk assessment and multidisciplinary management.
Overall, thrombophilia testing should be purpose-driven, evidence-based, and tailored to improve patient outcomes rather than performed routinely.”
Stay updated with Hemosyasis Today.
-
Oct 11, 2026, 12:11Carmine Siniscalchi: Could LDL Cholesterol Help Us Better Predict Bleeding Risk in Patients with VTE?
-
Oct 11, 2026, 12:03What is ITP? Raising Awareness for Immune Thrombocytopenia – ITP Australia and New Zealand
-
Oct 11, 2026, 11:55Gauri Jayasinghe: Privileged to Serve as Resource Person for the Blood Transfusion Essentials Programme
-
Oct 11, 2026, 11:49Toby Richards: New Definitions for Iron Deficiency Delighted to Be in the USA with the New ASH Guidelines
-
Oct 11, 2026, 11:44Lesley Van Wyk: ASCP High-Yield Review – Essential Thalassemia Concepts and Differential Diagnosis
-
Oct 11, 2026, 11:37Susanne Pass: Key Takeaways from ESVS 2026 Workshops in Belgrade
-
Oct 11, 2026, 10:44Logesh. M: Managing Warfarin-Associated Recurrent Epistaxis and Anticoagulant Safety
-
Oct 11, 2026, 10:28Sébastien Béland: Validating RUDAS for Detecting Neurocognitive Impairment in Sickle Cell Disease
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia